Skip to Content
주식/증권 📈 긍정적

Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 Earnings

요약

ELTP delivers record fiscal 2026 results, with stronger profits, improved cash and pipeline progress supporting its expanding generics platform.